Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy

被引：0
|
作者：
Lebkowski, Jane S. [1 ]
Khoury, Hanna J. [2 ]
Collins, Robert H. [3 ]
Blum, William [4 ]
Stiff, Patrick [5 ]
Wirth, Edward [6 ]
Nishimoto, Kevin [6 ]
DiPersio, John [7 ]
机构：
[1] Asterias Biotherapeut, Portola Valley, CA USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] UT Southwestern, Dallas, TX USA
[4] Ohio State Univ, Columbus, OH 43210 USA
[5] Loyola Univ, Maywood, IL 60153 USA
[6] Asterias Biotherapeut, Fremont, CA USA
[7] Washington Univ, St Louis, MO USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33085-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
276
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [11] Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia (AML) predicts superior relapse-free survival
    Elliott, Michelle A.
    Litzow, Mark R.
    Letendre, Louis
    Wolf, Robert C.
    Hanson, Curtis A.
    Tefferi, Ayalew
    Tallman, Martin S.
    BLOOD, 2007, 110 (11) : 547A - 547A
  • [12] Stroma-Free Long-Term Growth of Primary Acute Myeloid Leukemia (AML) Cells
    Chen, Jing
    Calder, Paul
    Ibanez-Sanchez, Glorymar
    Frattini, Mark
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S292 - S292
  • [13] Total body irradiafion (TBI) added to fludarabine/busulfan/antithymocyte gobulin (FLUBUP/ATG) conditioning increases overall survival and relapse-free survival in patients with acute myeloid leukemia (AML) receiving allogeneic stem cell transplants.
    Savoie, Mary Lynn
    Balogh, Alexander
    Chaudhry, Ahsan
    Stewart, Douglas A.
    Bahlis, Nizar J.
    Storek, Jan
    Brown, Christopher
    Quinlan, Diana
    Kmet, Leanne
    Larratt, Loree M.
    Turner, A. Robert
    Russell, James A.
    BLOOD, 2006, 108 (11) : 854A - 854A
  • [14] Effect of disease status prior to T-cell depleted allogeneic stem cell transplantation on relapse-free and overall survival in patients with adverse-risk acute myeloid leukemia (AML)
    Rojek, Alexandra Ewa
    Mortel, Mylove
    Artz, Andrew S.
    Larson, Richard A.
    Liu, Hongtao
    Nawas, Mariam
    Odenike, Olatoyosi
    Stock, Wendy
    Bishop, Michael Russell
    Kosuri, Satyajit
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [15] Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experience
    Vignetti, M
    Orsini, E
    Petti, MC
    Moleti, ML
    Andrizzi, C
    Pinto, RM
    Amadori, S
    Meloni, G
    ANNALS OF ONCOLOGY, 1996, 7 (09) : 933 - 938
  • [16] Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
    Michallet, M.
    Benet, T.
    Sobh, M.
    Kraghel, S.
    El Hamri, M.
    Cannas, G.
    Nicolini, F. E.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Thomas, X.
    Chelghoum, Y.
    Nicolle, M-C
    Bienvenu, A-L
    Persat, F.
    De Monbrison, F.
    Picot, S.
    Vanhems, P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (06) : 991 - 997
  • [17] Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
    M. Michallet
    T. Bénet
    M. Sobh
    S. Kraghel
    M. El Hamri
    G. Cannas
    F. E. Nicolini
    H. Labussière
    S. Ducastelle
    F. Barraco
    X. Thomas
    Y. Chelghoum
    M.-C. Nicolle
    A.-L. Bienvenu
    F. Persat
    F. De Monbrison
    S. Picot
    P. Vanhems
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 991 - 997
  • [18] Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Klinger, Matthias
    Kufer, Peter
    Stelljes, Matthias
    Viardot, Andreas
    Horst, Heinz A.
    Neumann, Svenja
    Brueggemann, Monika
    Ottmann, Oliver G.
    Burmeister, Thomas
    Wessiepe, Dorothea
    Topp, Max S.
    Bargou, Ralf
    HAEMATOLOGICA, 2017, 102 (04) : E132 - E135
  • [19] Long-term relapse-free survival enabled by integrating targeted antibacteria in antitumor treatment
    Wang, Yuanlin
    Han, Yaqian
    Yang, Chenhui
    Bai, Tiancheng
    Zhang, Chenggang
    Wang, Zhaotong
    Sun, Ye
    Hu, Ying
    Besenbacher, Flemming
    Chen, Chunying
    Yu, Miao
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [20] Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients
    de Bont, ESJM
    Fidler, V
    Meeuwsen, T
    Scherpen, F
    Hählen, K
    Kamps, WA
    CLINICAL CANCER RESEARCH, 2002, 8 (09) : 2856 - 2861
12345